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In the evaluation of syphilis therapy with penicillin, it has become increasingly
evident that the optimum treatment schedule has not yet been determined. The
questions of solution versus delayed absorption or excretion preparations, con-
tinuous or discontinuous treatment, time interval, etc., are still the subjects of
extensive laboratory and clinical investigation.
In a recent study (1) we reported on a continuous schedule of syphilis therapy
in which penicillin was administered once a day for sixteen consecutive days.
In this plan, it is assumed that there is a continuous effective concentration of
penicillin in the blood and tissues during the entire treatment course. This
schedule gave excellent clinical and serologic results and compared favorably
with the best schedules of syphilis therapy; however, the results were by no
means optimal.
The suggestion has variously been made that perhaps a broken schedule of
therapy in which penicillin is administered at relatively long intervals may pro-
duce equally good results and perhaps it is not necessary to have a continuous
concentration of penicillin in the blood and tissues to obtain optimal results.
It was with this in mind that the present study was undertaken.
In this investigation we are reporting on such an extended discontinuous treat-
ment schedule in which penicillin-oil-beeswax (P.O.B.) semifluid type was given
twice a week at intervals of three to four days. In this form of therapy it may
be safely assumed that there are relatively long periods of freedom from de-
tectable penicillin concentration in the blood.
One hundred sixty patients were subjected to this form of therapy. The treat-
ments were given in ambulatory clinic practice, and so mapped as not to interfere
in any way with the patients' normal routine. The treatments were administered
in the clinic at semi-weekly intervals, for an eight-weeks period. Each dose was
300,000 units of P.O.B.; the total dose was therefore 4,800,000 units. This is
exactly that employed in our previous sixteen-day continuous treatment schedule.
Of the total treated, 113 cases or seventy per cent, remained under observation
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for a period of eight months or longer following termination of treatment and
these constitute the basis of this report. A minimum of eight months post-
treatment observation was required in the cases, firstly, because relapses are
usually observed before the end of the eighth month and secondly, this eight-
months follow-up period was employed in evaluating the continuous treatment
schedule mentioned above. Thus it was possible for us to compare the two
schedules on an equal observation time basis.
The patients were of both sexes; 78 were males and 35 females; 84 were non-
white and 29 white patients. The ages varied from 19 to 55 years (Table I).
The blood specimens of all the patients were subjected to a battery of serologic
tests identical with those employed in our previous study; this too was for the
purpose of being able to compare the results in the two studies. The tests were
TABLE I
Color and sex distribution of 113 patients treated
ORIGINAL DIAGNOSIS
UNDRR OBSZRVATION
Patients Per cent
Seronegative primary
Seropositive primary
Secondary
8
40
65
7.1
35•4
57.5
Total 113
the Mazzini, V.D.R.L. (Venereal Disease Research Laboratory) Cardiolipin,
Kline Exclusion, Rein-Bossak Cardiolipin (microfiocculation test), Kolrner Com-
plement fixation test and a Cardiolipin Complement fixation test. Blood tests
were performed at monthly intervals with the exception that in the seronegative
primary cases they were done at bi-weekly intervals. All tests were processed in
a single laboratory by the same technicians at the New York Skin and Cancer
Unit, in order to avoid technical differences.
The cases treated were divided into the standard classification of seronegative
primary, seropositive primary and secondary syphilis. The diagnosis of sero-
negative primary syphilis was based on clinical grounds as well as on a positive
darkifeld examination. In addition to the clinical and often bacteriologic evi-
dence, a positive serologic test was present in the seropositive primary cases.
TABLE II
Classification of the 113 patients according to diagnosis
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Secondary syphilis was diagnosed on clinical evidence and the presence of a
positive serologic test; in many cases darkfield examinations proved positive.
The division of the cases according to the mentioned classification appears in
Table II.
The clinical response to therapy in all instances was uniformly satisfactory
and differed in no wise from the usual experience in short term schedules. Al-
though, as stated, a battery of tests was performed in all cases, the Mazzini
test alone was employed as the criterion for evaluating the material. This test
was likewise employed in evaluating the sixteen-day schedule previously reported.
RESULTS
The analysis of the results of therapy in the various groups is as follows:
1. Seronegative primary. Eight of the 12 cases were followed from eight to
seventeen months. All but one remained seronegative. The failure was a clinical
relapse twelve months post treatment. While this case is listed as a treatment
failure, he may well have been a reinfection. For a period of five months post
treatment, five serologic tests taken at monthly intervals proved negative. The
patient absented himself for seven months and returned presenting a generalized
maculo-papular eruption of the type seen in the very early lues (clinically it
resembled in no wise a relapsing syphilid). A history of repeated exposures was
obtained.
Of the four cases that were lost from observation before the eighth month,
one was negative at four months and three at five months, post treatment.
2. Sero positive primary cases. Of a total of 40 cases followed from eight to
seventeen months post-termination of treatment, 37 (92.5%) became seronega-
tive, 2 (5.0%) showed satisfactory serologic progress (1—2 units) and 1 (2.5%)
was a clinical failure.
3. Secondary cases. Of 65 followed from eight to nineteen months, 41(63.1%)
became seronegative, 14 (21.5%) showed a satisfactory serologic response (1—4
units), 4 (6.9%) showed unsatisfactory serologic progress (8 or more units), and
6 (9.2%) were clinical failures.
The drop in the serologic titre in the treated patients that have not attained
seronegativity but still remain under observation is detailed in Table III.
It will be observed that practically all cases showed a marked drop in the
serologic titre, indicating definite tendency toward seronegativity, but only those
are regarded as satisfactory in which the test had dropped to less than four units.
Findings above this figure we regard as unsatisfactory, and are classified as
serologic failures. Based upon this classification 16 (80%) of the cases showed a
satisfactory trend and 4 (20%) one that is not satisfactory. Of the unsatisfactory
cases one showed a titre of eight at the end of seventeen months; another a
titre of eight at sixteen months; the third, sixteen units at the end of fourteen
months (although the drop in this case was from an initial of 512 units) and the
fourth at the end of eight months, a titre of eight units. It is not unlikely that
most of these will completely fade out in the course of time without any further
therapy; this is common experience. On the other hand it is possible that some
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of the satisfactory cases with very low titres may relapse and become unsatis-
factory (Table III).
In connection with low titre serologic reactions in treated syphilis it is well to
point out that there is considerable evidence indicating that low titre serologic
reactions may in some instances really represent biologic false positive reactions,
for it has been observed that intercurrent infections, which usually raises the
serologic titre in false positive cases will do the same in low titre syphilis cases (2).
TABLE III
Serologic drop in titre in ca8eS still under observation
total—20 cases
DIAGNOSIS TITER AT ONSET TITRE AT PRESENT DSISATION OP OBSERVATION
Seropositive primary
i.J.J
2.H.G
4 1
64 2
months
9
14
Secondary
3.M.B
4.F.B
5.R.B
6.T.B
7.C.C
8.M.F
9.L.V
10.A.M
11.C.Mc
12.E.P
13.R.G
14. H. R
15.R.T
16. N. W
17.A.R
18.L.G
19.E.J
20.M.W
32
32
128
64
64
32
256
64
64
8
64
512
32
256
32
4
128
64
2
1
8
2
8
2
2
2
1
4
8
16
4
2
4
2
4
2
16
15
16
10
17
11
13
9
12
11
8
14
8
18
10
11
18
14
Clinical failures: There were eight clinical failures (relapses or reinfections).
The appended table (Table IV) furnishes the pertinent data in each case. While
some of the cases are undoubted relapses, in two (Cases 1 and 6) there is a strong
supposition that they are reinfections. It is difficult to prove the point one way
or the other.
Reactions: Remarkably few treatment reactions were observed and these con-
sisted of itching and several cases showing mild urticarial eruptions. This parallels
our findings in our sixteen-day schedule series when the semifluid P.O.B. was
used in therapy.
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Spinaifluid examination: Fifty-one patients were subjected to lumbar puncture
eight months or longer post treatment. All but three gave normal findings. The
abnormal findings the the three are: Case 1 (R. G.) original diagnosis secondary
syphilis; showed a serorelapse, 92 cells, Kolmer 4+, T.P. 38 mg.%, Col. Gold
2211000000. Case 2 (R. B.) original diagnosis secondary syphilis, showed a Kol-
mer 4+, T.P. 38 mg.%, Col. Gold 3222100000. Case 3 (M. F.) a case of secondary
TABLE IV
Analysis of patients showing relapses or reinfections
total—8 patients
PATIENT STAGE OF DISEASE
MONTHS POST
TREATMENT
REINFECTION
NATURE OP RELAPSE
1. D. B
2. J. W
3. Y. Y
4. D. T
5. H. S
6. M. M
7. W. B
8. A. L
Seronegative Primary
Seropositive Primary
Secondary
Secondary
Secondary
Secondary
Secondary
Secondary
12
11
4
4
12
10
10
8
Generalized secondaries
Mucocutaneous relapse
Generalized secondaries
Generalized secondaries
Mucocutaneous relapse
Penile primary
Generalized secondaries
Single papule on scrotum
TABLE V
ISummary and comparison of resulgs of therapy with P.O.B.
CMARGIN ET AL. 300,000 UNITS
DAILY TOTAL DOSAGE 4,800,000
SOBEL ET AL. 300,000 UNITS TWICE
WEEKLY TOTAL DOSAGE 4,800,000
No. Per cent No. Per cent
Seronegative primary
Remained seronegative
Relapse or reinfection
Seropositive primary
Became negative
Remained positive
Relapseorreinfection
Secondary
Became negative
Remained positive
Relapse or reinfection
13
13
0
51
47
2
2
83
62
17
4
100.0
100.0
0.0
100.0
92.2
4.0
4.0
100.0
74.7
20.5
4.8
8
7
1
40
37
2
1
65
41
18
6
100.0
87.5
12.5
100.0
92.5
5.0
2.5
100.0
63.1
27.7
9.2
syphilis, showed a cell count of 13, Kolmer negative, T.P. 19 mg.%, Col. Gold
negative.
The abnormal spinal fluid findings represent 6% of those performed, which
is much higher than in our sixteen-day series in which only one abnormal fluid
was found (increased cell count) in 90 cases.
Comparing this series with the sixteen-day series, Table V, shows that in
seronegative primary syphilis the results are comparable. The single failure re-
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ported in the twice-weekly series may have been a reinfection. In the seropositive
primary cases the results are almost identical; although there is a slight difference
in favor of the two-a-week therapy. The difference is not statistically significant.
In the secondary syphilis cases all three subdivisions show a poorer result by the
two-a-week as compared to the sixteen-day schedule. Sixty-three per cent of the
former against seventy-four per cent became seronegative. Twenty-seven per
cent of the former against twenty per cent of the latter remained seropositive;
and 9.2% against 4.8% had clinical relapses or reinfections.
COMMENT
The semi-weekly schedule of therapy lends itself very well to ambulatory
treatment since it interferes little with the normal routine of patients. However,
lapses from regular treatment so commonly observed in pre-penicillin days also
occur with this plan of treatment and must be counted against the semi-weekly
schedule. In this study twenty per cent of the patients originally placed under
treatment failed to take the full course of therapy. Many of these cases necessarily
remain reservoirs of infection because of inadequate therapy.
It is now possible to state that in primary syphilis, seronegative or seropositive,
all schedules of therapy give eminently satisfactory results. While they differ, it
is only to a slight degree. However, in secondary syphilis this does not hold true.
While some schedules give better results than others, none rates very high.
It is in this stage of syphilis that improved therapy is required and perhaps this
can be accomplished by additive treatment. It is with this in mind that we have
inaugurated a combined schedule of penicillin, arsenic and bismuth which should
furnish information respecting this important phase of syphilis therapy.
CONCLUSIONS
1. The twice-a-week schedule lends itself very well to ambulatory treatment.
2. Twenty per cent of the patients admitted did not complete treatment;
they constitute a source of new infections.
3. Seventy per cent of the patients who completed treatment remained under
observation for eight to nineteen months, post-treatment.
4. The results in primary syphilis, seronegative and seropositive, compare
favorably with the sixteen-day schedule of treatment.
5. In secondary syphilis the results are less satisfactory.
6. The spinal fluid results show a higher percentage of abnormal findings with
the twice-a-week schedule than with the 16-day schedule.
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